ConductScience.org, home

Paper41301028

The Involvement of the Peptidergic Systems in Breast Cancer Development.

Sánchez ML and 5 others. Cancers (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. The Involvement of the Peptidergic Systems in Breast Cancer Development. Papers, record 41301028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301028

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Involvement of the Peptidergic Systems in Breast Cancer Development.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References285

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128423716Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.Oncotarget2017https://conductscience.org/library/papers/28423716PubMed
236732798Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus.Mol Brain2023https://conductscience.org/library/papers/36732798PubMed
324412750CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.Cell Signal2014https://conductscience.org/library/papers/24412750PubMed
436980580Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.Cancers (Basel)2023https://conductscience.org/library/papers/36980580PubMed
533477190Growth Promotion and Increased ATP-Binding Cassette Transporters Expression by Liraglutide in Triple Negative Breast Cancer Cell Line MDA-MB-231.Drug Res (Stuttg)2021https://conductscience.org/library/papers/33477190PubMed
634236041New drug delivery strategies targeting the GnRH receptor in breast and other cancers.Endocr Relat Cancer2021https://conductscience.org/library/papers/34236041PubMed
735011543The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells.Molecules2022https://conductscience.org/library/papers/35011543PubMed
823932937Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.Peptides2013https://conductscience.org/library/papers/23932937PubMed
938004416Preparation, Radiolabeling with 68Ga/177Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38004416PubMed
1037816015Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.PLoS One2023https://conductscience.org/library/papers/37816015PubMed
1134767373The Neuropeptide Y1 Receptor Ligand-Modified Cell Membrane Promotes Targeted Photodynamic Therapy of Zeolitic Imidazolate Frameworks for Breast Cancer.J Phys Chem Lett2021https://conductscience.org/library/papers/34767373PubMed
1226702849Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.Curr Opin Endocrinol Diabetes Obes2016https://conductscience.org/library/papers/26702849PubMed
1330451597Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis.Per Med2019https://conductscience.org/library/papers/30451597PubMed
1425540945Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis.J Neurogastroenterol Motil2015https://conductscience.org/library/papers/25540945PubMed
1523844294Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.ISRN Oncol2013https://conductscience.org/library/papers/23844294PubMed
169529167Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.Circ Res1998https://conductscience.org/library/papers/9529167PubMed
1730132865Antitumor activity of cell-penetrant kinin B1 receptor antagonists in human triple-negative breast cancer cells.J Cell Physiol2019https://conductscience.org/library/papers/30132865PubMed
1834104122Investigation of Specific Targeting of Triptorelin-Conjugated Dextran-Coated Magnetite Nanoparticles as a Targeted Probe in GnRH+ Cancer Cells in MRI.Contrast Media Mol Imaging2021https://conductscience.org/library/papers/34104122PubMed
193600678Neuroimmunomodulation with enkephalins: in vitro enhancement of natural killer cell activity in peripheral blood lymphocytes from cancer patients.Nat Immun Cell Growth Regul1987https://conductscience.org/library/papers/3600678PubMed
2019156213The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression.PLoS One2009https://conductscience.org/library/papers/19156213PubMed

See all 285 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42122143Targeting Peptidergic Systems for Melanoma Treatment.Cancers (Basel)2026https://conductscience.org/library/papers/42122143

Source PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301028

GET https://conductscience.org/api/papers/v1/41301028/references?page=2